Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2
NCT05715944
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
10888
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
AZD 1222
Sponsor
Botswana Harvard AIDS Institute Partnership
Collaborators
[object Object]
[object Object]